Avidity Biosciences (RNA) PT Raised to $71 at Raymond James following bullish data
Tweet Send to a Friend
Raymond James analyst Steven Seedhouse raised the price target on Avidity Biosciences (NASDAQ: RNA) to $71.00 (from $30.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
